• Are drug expiration dates fit for purpose?

    It’s long been a quietly accepted fact that many drugs are safe and potent long after they pass their official expiration dates. Given the potential waste that goes unnoticed when...

  • CERN-MEDICIS: backing nuclear medicine

    Radioactive isotopes are a potentially transformative source of innovative diagnostics and treatments, especially for cancer. The CERN-MEDICIS project aims to use excess ‘beam dumps’ at CERN to produce a steady...

  • Pharma Technology Focus – Issue 63

    In this issue: UK pharma industry takes NICE to court over price caps, Amazon’s potential to enter the US pharmacy industry, a new platform to capture molecules from fungi, the...

  • Mining fungi: a fountain of new medicines?

    While fungi are a rich source of natural molecules, it has historically been hard to identify and capture these in a systematic way. Now a new technology platform, developed by...

  • Pharma Technology Focus – Issue 62

    In this issue: A new tool to encourage links between industry and academia, blockchain’s applications for pharma, using Zika to attack brain tumour cells, treating MS with nanotechnology, the benefits...

  • Zika virus: an unlikely new anti-cancer candidate

    Scientists at Cambridge University, funded by Cancer Research UK, are investigating the potential for Zika virus to be weaponised against brain tumour cells. The researchers have received funding to test...